API reference

Finerenone

CAS number
1050477-31-0
Molecular formula
C21H22N4O3
Molecular weight
378.4 g/mol
Finerenone — 2D structure
2D structure (PubChem)

About this molecule

Finerenone is an orally bioavailable non-steroidal mineralocorticoid receptor antagonist (MRA), with anti-fibrotic and anti-inflammatory activities. Upon oral administration, finerenone targets and binds to the mineralocorticoid receptor (MR), and inhibits MR-mediated sodium reabsorption and overactivation in both epithelial and nonepithelial tissues. This reduces fibrosis and inflammation that result from MR overactivation.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
InChIKey
BTBHLEZXCOBLCY-QGZVFWFLSA-N
SMILES
CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
PubChem CID
60150535

Also known as

Finerenone · Kerendia · finerenona · finerenonum · 814-499-5 · Finerenone (JAN/USAN/INN) · Finerenon · Finerenone?

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com